Priyamvada Maitre, Radiation Oncologist at the Department of Radiation Oncology, Tata Memorial Centre, shared a post on X about a paper she co-authored with colleagues published in Prostate Cancer and Prostatic Diseases:
“New Paper. Systemic treatment high in PSMA-staged high-risk prostate cancer – is RT+ADT good enough? Congrats Ashesh! Builds on the ESTRO 2025 debate on radiotherapy vs immunotherapy for high-risk prostate cancer by Vedang Murthy. Check out the new trial RELAX on this Q!”
Title: Abiraterone for “STAMPEDE-Like” cohort of high-risk prostate cancer in the PSMA-PET era: too much, too early?
Authors: Vedang Murthy, Asesh Samanta, Priyamvada Maitre, Prashant Nayak, Pallavi Singh, Archi Agrawal, Amit Joshi, Gagan Prakash.
You can read the Full Article in Prostate Cancer and Prostatic Diseases.
More posts featuring Priyamvada Maitre.
